B+
Composite 7.5 / 10
Last updated 2026-04-29. Composite is computed from the live database; missing sub-scores redistribute weight across the others.
Editorial summary
A grades on Tirzepatide (9 tests, avg 8.7) and Semaglutide (11 tests). Tighter score consistency than top peers.
Peptide breakdown
| Peptide | Score | Lab quality | Tests | Purity | Qty var. | $/mg verified | Last test | Ranking |
|---|---|---|---|---|---|---|---|---|
| Tirzepatide | 8.7B+ |
8.7 | 9 | 98.7% | — | — | 2026-03-25 | view |
| Retatrutide | 8.5B+ |
8.5 | 8 | 99.4% | — | — | 2026-03-25 | view |
| Semaglutide | 8.5B+ |
8.5 | 11 | 99.0% | — | — | 2026-03-25 | view |
| Ipamorelin | 8.2B+ |
8.2 | 5 | 98.8% | — | — | 2026-03-25 | view |
COA transparency
- ✓ Publishes per-batch COAs (not just one COA for everyone)
- ✓ Both HPLC and mass spec shown
- ○ Endotoxin or sterility data shown (pending)
- ○ At least one COA independently cross-checked (pending)
- ✓ Most recent COA within 90 days (2026-03-25)
All vendor grades, side-by-side
Compare Aavant Research against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.